Takeaways of AP report on DEA probe of drug distributor accused of fueling opioid epidemic
The U.S. Drug Enforcement Administration has allowed one of the nation’s largest drug distributors to keep shipping addictive painkillers for nearly four years despite a judge’s recommendation to strip its license for turning a blind eye to thousands of suspicious opioid orders
By JIM MUSTIAN and JOSHUA GOODMAN
Published - May 24, 2023, 02:27 AM ET
Last Updated - Jun 21, 2023, 04:44 PM EDT
SHREVEPORT, La. (AP) — The U.S. Drug Enforcement Administration has allowed one of the nation’s largest wholesale drug distributors to keep shipping addictive painkillers for nearly four years despite a judge’s recommendation to strip its license for turning a blind eye to thousands of suspicious opioid orders.
The case has drawn attention to the involvement of a high-profile consultant the company had hired to stave off punishment and who is now DEA Administrator Anne Milgram’s top deputy.
Here are the key takeaways:
WHAT’S AT STAKE?
